Drug Type Small molecule drug |
Synonyms Calcipotriol and Betamethasone Dipropionate Gel, Calcipotriol and Betamethasone Ointment, 倍他米松/卡泊三醇 + [3] |
Target |
Mechanism GR agonists(Glucocorticoid receptor agonists), VDR agonists(Vitamin D receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date CN (25 Jun 2013), |
Regulation- |
Molecular FormulaC27H40O3 |
InChIKeyLWQQLNNNIPYSNX-UROSTWAQSA-N |
CAS Registry112965-21-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Psoriasis | CN | 25 Jun 2013 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Scalp Dermatoses | Phase 3 | BE | 01 Dec 2004 | |
Scalp Dermatoses | Phase 3 | CA | 01 Dec 2004 | |
Scalp Dermatoses | Phase 3 | FI | 01 Dec 2004 | |
Scalp Dermatoses | Phase 3 | FR | 01 Dec 2004 | |
Scalp Dermatoses | Phase 3 | DE | 01 Dec 2004 | |
Scalp Dermatoses | Phase 3 | NL | 01 Dec 2004 | |
Scalp Dermatoses | Phase 3 | GB | 01 Dec 2004 | |
Rosacea | Phase 2 | US | 01 Sep 2011 | |
Arthritis | Phase 2 | DE | 01 Sep 2009 | |
Psoriasis vulgaris | IND Approval | CN | 11 Aug 2020 |
Not Applicable | - | zbikubucpx(ubqugrfype) = 0.8%/0.1% vs 7.4% tatpdfqlum (kezabrgioy ) View more | - | 12 May 2022 | |||
Phase 2 | 33 | ulnwlaqlab(cluezioqum) = kbmpluuzag mnqdmcwerp (oweoqcowfg, iontbsllal - bnalkvcusy) View more | - | 07 Jan 2013 |